drugset / Trial / NCT01709422

Efficacy and Safety Profiles of Combination Sedation Propofol With Midazolam and Meperidine.

NCT01709422

Phase 4 Completed 140 enrolled Prince of Songkla University
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to compare efficacy and safety of combination of propofol and midazolam with meperidine versus midazolam and meperidine for ambulatory ERCP

Timeline

Start
2010-06
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Meperidine Unknown 5 mg Intravenous
Comparator Meperidine Unknown 10 mg Intravenous
Comparator Midazolam Small molecule 0.5 mg Intravenous
Comparator Midazolam Small molecule 1 mg Intravenous
Comparator Propofol Small molecule 5 mg Intravenous
Comparator Propofol Small molecule 10 mg Intravenous